phenethylamine has been researched along with Cholera Infantum in 2 studies
phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016
2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of gastrointestinal disorders of CRP, AFI and AF is associated with their alkaloid component N-methyltyramine via the regulation of ARs, and the mechanism is considered to be the biotransformation of N-methyltyramine to epinephrine by serial synthase, which takes place at the nerves cells in small intestine." | 1.51 | Effect of N-methyltyramine on the regulation of adrenergic receptors via enzymatic epinephrine synthesis for the treatment of gastrointestinal disorders. ( Bai, G; Chang, N; Cheng, D; Guo, Y; Jiang, M; Ni, J; Yan, M, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ni, J | 1 |
| Guo, Y | 1 |
| Chang, N | 1 |
| Cheng, D | 1 |
| Yan, M | 1 |
| Jiang, M | 1 |
| Bai, G | 1 |
| Levine, DJ | 1 |
| Runčevski, T | 1 |
| Kapelewski, MT | 1 |
| Keitz, BK | 1 |
| Oktawiec, J | 1 |
| Reed, DA | 1 |
| Mason, JA | 1 |
| Jiang, HZ | 1 |
| Colwell, KA | 1 |
| Legendre, CM | 1 |
| FitzGerald, SA | 1 |
| Long, JR | 1 |
2 other studies available for phenethylamine and Cholera Infantum
| Article | Year |
|---|---|
Effect of N-methyltyramine on the regulation of adrenergic receptors via enzymatic epinephrine synthesis for the treatment of gastrointestinal disorders.
Topics: Alkaloids; Animals; Citrus; Drugs, Chinese Herbal; Epinephrine; Fruit; Gastrointestinal Diseases; In | 2019 |
Olsalazine-Based Metal-Organic Frameworks as Biocompatible Platforms for H2 Adsorption and Drug Delivery.
Topics: Adsorption; Aminosalicylic Acids; Binding Sites; Biocompatible Materials; Chemistry, Organic; Drug C | 2016 |